<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (PCNSL), observed among immunocompromised <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients, has not been reported during chemotherapy for <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL) </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of PCNSL occurring in a child receiving intensive multiagent chemotherapy for B-cell ALL </plain></SENT>
<SENT sid="2" pm="."><plain>In situ hybridization studies demonstrated Epstein-Barr virus genome in both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, suggesting a possible link between the two diseases </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical response of the PCNSL to conservative therapy highlights the importance of accurately diagnosing such EBV-related disorders, especially in patients where immune compromise can be reversed </plain></SENT>
</text></document>